🎉 M&A multiples are live!
Check it out!

Ipca Laboratories Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ipca Laboratories and similar public comparables like Pharming, Galapagos, and Vivoryon Therapeutics.

Ipca Laboratories Overview

About Ipca Laboratories

Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.


Founded

1949

HQ

India
Employees

17.3K+

Website

ipca.com

Financials

LTM Revenue $1.0B

LTM EBITDA $202M

EV

$4.0B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Ipca Laboratories Financials

Ipca Laboratories has a last 12-month revenue of $1.0B and a last 12-month EBITDA of $202M.

In the most recent fiscal year, Ipca Laboratories achieved revenue of $885M and an EBITDA of $155M.

Ipca Laboratories expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Ipca Laboratories valuation multiples based on analyst estimates

Ipca Laboratories P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $721M $885M XXX XXX XXX
Gross Profit $425M $441M XXX XXX XXX
Gross Margin 59% 50% XXX XXX XXX
EBITDA $122M $155M XXX XXX XXX
EBITDA Margin 17% 18% XXX XXX XXX
Net Profit $103M $54.7M XXX XXX XXX
Net Margin 14% 6% XXX XXX XXX
Net Debt $59.9M $23.2M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Ipca Laboratories Stock Performance

As of April 15, 2025, Ipca Laboratories's stock price is INR 1332 (or $15).

Ipca Laboratories has current market cap of INR 338B (or $3.9B), and EV of INR 340B (or $4.0B).

See Ipca Laboratories trading valuation data

Ipca Laboratories Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$4.0B $3.9B XXX XXX XXX XXX $0.42

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Ipca Laboratories Valuation Multiples

As of April 15, 2025, Ipca Laboratories has market cap of $3.9B and EV of $4.0B.

Ipca Laboratories's trades at 3.8x LTM EV/Revenue multiple, and 19.6x LTM EBITDA.

Analysts estimate Ipca Laboratories's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Ipca Laboratories and 10K+ public comps

Ipca Laboratories Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $4.0B XXX XXX XXX
EV/Revenue 4.0x XXX XXX XXX
EV/EBITDA 20.9x XXX XXX XXX
P/E 41.1x XXX XXX XXX
P/E/Growth 1.3x XXX XXX XXX
EV/FCF 44.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Ipca Laboratories Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Ipca Laboratories Valuation Multiples

Ipca Laboratories's NTM/LTM revenue growth is 13%

Ipca Laboratories's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $27K for the same period.

Over next 12 months, Ipca Laboratories's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Ipca Laboratories's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Ipca Laboratories and other 10K+ public comps

Ipca Laboratories Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 23% XXX XXX XXX XXX
EBITDA Margin 19% XXX XXX XXX XXX
EBITDA Growth 27% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 32% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $27K XXX XXX XXX XXX
S&M Expenses to Revenue 9% XXX XXX XXX XXX
G&A Expenses to Revenue 2% XXX XXX XXX XXX
R&D Expenses to Revenue 1% XXX XXX XXX XXX
Opex to Revenue 52% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Ipca Laboratories Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Ipca Laboratories M&A and Investment Activity

Ipca Laboratories acquired  XXX companies to date.

Last acquisition by Ipca Laboratories was  XXXXXXXX, XXXXX XXXXX XXXXXX . Ipca Laboratories acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Ipca Laboratories

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Ipca Laboratories

When was Ipca Laboratories founded? Ipca Laboratories was founded in 1949.
Where is Ipca Laboratories headquartered? Ipca Laboratories is headquartered in India.
How many employees does Ipca Laboratories have? As of today, Ipca Laboratories has 17.3K+ employees.
Who is the CEO of Ipca Laboratories? Ipca Laboratories's CEO is Mr. Pranay Godha.
Is Ipca Laboratories publicy listed? Yes, Ipca Laboratories is a public company listed on BOM.
What is the stock symbol of Ipca Laboratories? Ipca Laboratories trades under 524494 ticker.
When did Ipca Laboratories go public? Ipca Laboratories went public in 1994.
Who are competitors of Ipca Laboratories? Similar companies to Ipca Laboratories include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Ipca Laboratories? Ipca Laboratories's current market cap is $3.9B
What is the current revenue of Ipca Laboratories? Ipca Laboratories's last 12-month revenue is $1.0B.
What is the current EBITDA of Ipca Laboratories? Ipca Laboratories's last 12-month EBITDA is $202M.
What is the current EV/Revenue multiple of Ipca Laboratories? Current revenue multiple of Ipca Laboratories is 3.8x.
What is the current EV/EBITDA multiple of Ipca Laboratories? Current EBITDA multiple of Ipca Laboratories is 19.6x.
What is the current revenue growth of Ipca Laboratories? Ipca Laboratories revenue growth between 2023 and 2024 was 23%.
Is Ipca Laboratories profitable? Yes, Ipca Laboratories is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.